シャル
commented on
With the profit from the Tokyo Metro's listing, the next thing is $Celestica (CLS.US)$ Keep an eye on the toro!
The financial results announced this morning, while there are some dissatisfactory points, overall it was not a bad outcome. Attention will be drawn to the movement of the stock price after the financial results.
Financial results
[Revenue]: The CCS segment has seen a significant growth of 42% due to the increase in AI/ML computing demand.exp.On the other hand, the ATS segment experienced a decrease in demand from the industrial and capital equipment businesses.5% decreasehas occurred.
[Cash Flow]: Cash flow from operating activities is 0.1 billion 44.8 million dollars, an increase from the same period last yearsignificantly increasedDid.
[EPS Forecast]: According to Gemini Advance's unique analysis, the forecast for the fiscal year ending March 2025 is 4.00 dollars, and for the fiscal year ending December 20254.00 dollarsisThe price is $4.42.Fiscal year ending December 2026Expected to be $4.90.We expect.
The growth of the CCS segment is expected to continue, and the ATS segment is also expected to recover in the second half of 2024. However, there are several points to note, such as the delay in the recovery of the ATS segment and the focus on the CCS segment.
$Celestica (CLS.US)$
The financial results announced this morning, while there are some dissatisfactory points, overall it was not a bad outcome. Attention will be drawn to the movement of the stock price after the financial results.
Financial results
[Revenue]: The CCS segment has seen a significant growth of 42% due to the increase in AI/ML computing demand.exp.On the other hand, the ATS segment experienced a decrease in demand from the industrial and capital equipment businesses.5% decreasehas occurred.
[Cash Flow]: Cash flow from operating activities is 0.1 billion 44.8 million dollars, an increase from the same period last yearsignificantly increasedDid.
[EPS Forecast]: According to Gemini Advance's unique analysis, the forecast for the fiscal year ending March 2025 is 4.00 dollars, and for the fiscal year ending December 20254.00 dollarsisThe price is $4.42.Fiscal year ending December 2026Expected to be $4.90.We expect.
The growth of the CCS segment is expected to continue, and the ATS segment is also expected to recover in the second half of 2024. However, there are several points to note, such as the delay in the recovery of the ATS segment and the focus on the CCS segment.
$Celestica (CLS.US)$